BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
VEGFA
,
calcium channel activity
,
Diabetes mellitus
,
Leukocyte
,
Doxycycline
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vaccines leishmaniasis
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
LAMP3
SIGLEC1
ETV7
SERPING1
GBP1P1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN
HALLMARK_INTERFERON_GAMMA_RESPONSE
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Whole blood of subjects with ChAd63-KH leishmaniasis vaccination
Explore Curated Studies Results
Literature
Most Relevant Literature
Preclinical Assessment of the Immunogenicity of Experimental Leishmania Vaccines.
Leishmania Vaccines: the Current Situation with Its Promising Aspect for the Future.
Human leishmaniasis vaccines: Use cases, target population and potential global demand.
Therapeutic vaccines for leishmaniasis.
Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Developme…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleuk…
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis
Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasi…
A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leish…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ